Diamyd Medical AB (OSTO:DMYD B) Capex-to-Operating-Cash-Flow : 0.00 (As of May. 2025)

Diamyd Medical AB Capex-to-Operating-Cash-Flow Chart

Diamyd Medical AB Annual Data
	Trend	Aug15	Aug16	Aug17	Aug18	Aug19	Aug20	Aug21	Aug22	Aug23	Aug24
Capex-to-Operating-Cash-Flow		Get a 7-Day Free Trial					0.12	-	-	-	-

Diamyd Medical AB Quarterly Data
	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25
Capex-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Diamyd Medical AB's Capex-to-Operating-Cash-Flow

For the Biotechnology subindustry, Diamyd Medical AB's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diamyd Medical AB's Capex-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Diamyd Medical AB's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Diamyd Medical AB's Capex-to-Operating-Cash-Flow falls into.

Diamyd Medical AB Capex-to-Operating-Cash-Flow Calculation

Diamyd Medical AB's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Aug. 2024 is calculated as

Diamyd Medical AB's Capex-to-Operating-Cash-Flow for the quarter that ended in May. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diamyd Medical AB  (OSTO:DMYD B) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.

Diamyd Medical AB Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Diamyd Medical AB Business Description